Who can administer
  
                  May be administered by registered competent doctor or nurse/midwife (doctor present)
      
  
        Available preparations
  
                  Betaloc 5mg per 5ml ampoule
      
  
        Reconstitution
  
                  Already in solution
Draw up using a 5micron filter needle
      
  
        Infusion fluids
  
                  Sodium chloride 0.9% or Glucose 5% (ref 1)
      
  
        Methods of intravenous administration
  
                  Slow intravenous injection (preferred)
- Administer at a rate of 1 to 2mg per minute
 
- If necessary, may be diluted with Sodium chloride 0.9% or Glucose 5% (ref 1)
 
Intermittent intravenous infusion (unlicensed)
- Dilute 20mg to 50ml infusion fluid
 
- Suggested starting rate 40micrograms/kg/hour (=7ml/hour for a 70kg patient)
 
- Titrate dose according to response, usually up to 100 micrograms/kg/hour (ref 1)
 
      
  
        Dose in adults
  
                  The dose must always be adjusted to the individual requirements of the patient. The following are guidelines:
Cardiac arrhythmias
- Initially, up to 5mg at rate of 1 to 2mg per minute, repeated after five minutes if necessary. A total dose of 10 to 15mg generally proves sufficient
 
- Due to risk of pronounced drop in blood pressure, special care should be taken if systolic blood pressure is less than 100mmHg
 
During Anaesthesia
- Give 2 to 4mg injected slowly at induction to prevent (or during, to control) arrhythmias during anaesthesia
 
- Further doses of 2mg may be given as required to a maximum overall dose of 10mg
 
Early intervention within 12 hours of Myocardial Infarction 
- Give 5mg intravenously every two minutes to a max of 15mg as determined by blood pressure and heart rate
 
- The second and third iv dose should not be given if the systolic blood pressure is <90mmHg, the heart rate <40 bpm and the P-Q time is > 0.26 seconds, or if any aggravation of dyspnoea or cold sweating
 
- Oral therapy should commence 15 minutes after last injection with 50mg orally every six hours for forty-eight hours
 
- Patients who fail to tolerate the full intravenous dose should be given half the suggested oral dose
 
Hypertension in patients unable to take oral medication (ref 2)
- A range of oral/IV conversion ratios has been found from 2.5:1 to 5:1
 
- Patient variability may exist and a specific ratio may not apply to all patients, especially if co-morbid conditions are present.
 
- The estimated equivalent IV total daily dose should be divided into four equal doses.
 
- For example if a patient is receiving a chronic oral dose of 25mg bd, (total daily dose of 50mg) - this would translate to 2.5 to 5mg every six hours by intravenous injection
 
- Recognising that patients receiving larger chronic oral doses should not be automatically converted to a large IV dose, consideration should be given to further reducing the initial IV dose and basing subsequent doses on the clinical response
 
- Avoid abrupt withdrawal
 
Liver impairment
- Depending on severity, a reduction in dosage may be required (rarely needed)
 
      
  
        Monitoring
  
                  
- Monitor ECG, heart rate and blood pressure closely
 
      
  
        Storage
  
                  
      
  
        References
  
                  SPC February 2024
1: Medusa. Injectable medicines guide- downloaded 30/01/2025
2: UptoDate metoprolol drug information - downloaded 30/01/2025
      
  
        Therapeutic classification
  
                  Beta-adrenoceptor blocking drugs